Telomir Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Material agreementOct 6 →InsidersNo open-market buys or sales.→HoldersVanguard 2.3%Geode 0.5%BlackRock 0.4%→Financing →PeersClosest companies: INDP, COYA, OSRH→
From the filings
Figures
- Net income
- −$5.9Mlast 12 months
- Operating cash flow
- −$4.6Mlast 12 months
- Cash and equivalents
- $754,323at the last balance sheet
- Shares outstanding
- 68.8M shareson issue